Cambridge Wide Open Week 2026 has unveiled further details of its highly anticipated event, running from 11-19 June, as the ...
One-carbon Therapeutics, a clinical-stage biotechnology company pioneering first-in-class cancer therapies, has appointed ...
Hypertension affects more than 1.4 billion people worldwide and many patients remain uncontrolled despite multiple therapies ...
Cuttsy+Cuttsy has launched The Experience Gap, a practical roadmap designed to help clinical trial teams improve participant ...
AMR Bio has launched as a clinical phase biotechnology company focused on antimicrobial resistance. The company is advancing ...
LEO Pharma, in partnership with Allergy UK, has launched ‘Don’t Ignore’, a new out of home (OOH) awareness campaign designed to put the spotlight on chronic hand eczema (CHE). Rolling out in everyday, ...
Bristol Myers Squibb (BMS) has announced a strategic agreement with Anthropic to deploy Claude across the company’s research, ...
Breakthrough therapies do not fail because the science stops working. They fail when healthcare is not designed for the ...
GSK has signed a new three-year agreement with Protas that aims to streamline trials across several core therapeutic areas.
Novartis has started construction on its new 46,000 sq. ft radioligand therapy (RLT) manufacturing site in Denton, Texas, the ...
Regeneron has announced a strategic research collaboration with Parabilis Medicines to discover and develop multiple ...
AstronauTx has ppointed Michelle Mellion (pictured) as Chief Medical Officer (CMO) and Deb Gouveia as Vice President, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results